Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Duan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Metabolism and Drug Interactions|April 23, 2010
Population pharmacokinetics with a very small sample sizeIftekhar Mahmood, John Duan
Plos One|October 11, 2016
Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in AdultsXiaoxia Yang, John Duan, Jeffrey Fisher
The AAPS Journal|April 22, 2015
Applications of In Vitro-In Vivo Correlations in Generic Drug Development: Case StudiesParamjeet Kaur, Xiaojian Jiang, John Duan, et al.
The AAPS Journal|August 3, 2016
Regulatory Experience with In Vivo In Vitro Correlations (IVIVC) in New Drug ApplicationsSandra Suarez-Sharp, Min Li, John Duan, et al.
The AAPS Journal|September 22, 2016
Scientific and Regulatory Considerations in Solid Oral Modified Release Drug Product DevelopmentMin Li, Sanna Sander, John Duan, et al.
The AAPS Journal|March 2, 2016
Regulatory Perspectives on Strength-Dependent Dissolution Profiles and Biowaiver Approaches for Immediate Release (IR) Oral Tablets in New Drug ApplicationsSandra Suarez-Sharp, Poonam R Delvadia, Angelica Dorantes, et al.
The AAPS Journal|February 23, 2021
Biopharmaceutics Applications of Physiologically Based Pharmacokinetic Absorption Modeling and Simulation in Regulatory Submissions to the U.S. Food and Drug Administration for New DrugsFang Wu, Heta Shah, Min Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimenJohn R Johnson, Martin Cohen, Rajeshwari Sridhara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemiaMartin H Cohen, Grant Williams, John R Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2012
Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summaryKatherine Thornton, Geoffrey Kim, V Ellen Maher, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Drug Interactions|April 23, 2010
Population pharmacokinetics with a very small sample sizeIftekhar Mahmood, John Duan
Plos One|October 11, 2016
Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in AdultsXiaoxia Yang, John Duan, Jeffrey Fisher
The AAPS Journal|April 22, 2015
Applications of In Vitro-In Vivo Correlations in Generic Drug Development: Case StudiesParamjeet Kaur, Xiaojian Jiang, John Duan, et al.
The AAPS Journal|August 3, 2016
Regulatory Experience with In Vivo In Vitro Correlations (IVIVC) in New Drug ApplicationsSandra Suarez-Sharp, Min Li, John Duan, et al.
The AAPS Journal|September 22, 2016
Scientific and Regulatory Considerations in Solid Oral Modified Release Drug Product DevelopmentMin Li, Sanna Sander, John Duan, et al.
The AAPS Journal|March 2, 2016
Regulatory Perspectives on Strength-Dependent Dissolution Profiles and Biowaiver Approaches for Immediate Release (IR) Oral Tablets in New Drug ApplicationsSandra Suarez-Sharp, Poonam R Delvadia, Angelica Dorantes, et al.
The AAPS Journal|February 23, 2021
Biopharmaceutics Applications of Physiologically Based Pharmacokinetic Absorption Modeling and Simulation in Regulatory Submissions to the U.S. Food and Drug Administration for New DrugsFang Wu, Heta Shah, Min Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimenJohn R Johnson, Martin Cohen, Rajeshwari Sridhara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemiaMartin H Cohen, Grant Williams, John R Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2012
Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summaryKatherine Thornton, Geoffrey Kim, V Ellen Maher, et al.
Pageof 1